Daniel Bednarik, Ph.D. Historical Biosketch and Core Skills

Daniel Bednarik is a seasoned expert in cardiovascular genomics and infectious diseases in the context of translational research.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend

Highland, MD (PRWEB) January 05, 2014

Dr. Daniel Bednarik was previously Director of Genomics and Bioinformatics for Cardiome Pharma Corporation. He was a co-founder and Vice President of Cardiovascular Biology of Artesian Therapeutics, Inc., which was acquired by Cardiome in 2005. Dr. Bednarik served as a consultant for Cardiome for two years and was subsequently hired in 2007 to develop genomic and proteomic biomarker programs to help augment and accelerate clinical trial design. He created the largest known cardiovascular gene expression database for Gene Logic. Dr. Bednarik served as a key scientist for the development of Human Genome Sciences’ (HGS) database and has over 28 years experience in the field of virology with emphasis on HIV and herpes virus molecular biology and pathology. He was co-recipient of a Government DARPA contract in 2006 where he and his colleagues developed a novel non-host method for rapid vaccine manufacture utilizing a non-host baculovirus system. Dan also is experienced in developing and managing clinical programs. His training was completed at Temple University School of Medicine (Philadelphia) in 1985, and The Johns Hopkins University Oncology Center (Baltimore) in 1989. Daniel's current professional status can be viewed on his LinkedIn public profile.



  • Daniel Bednarik, Ph.D.

Follow us on: Contact's LinkedIn